CTI BIOPHARMA CORP Quarterly Common Stock, Shares, Issued from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cti Biopharma Corp quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q1 2023.
  • Cti Biopharma Corp Common Stock, Shares, Issued for the quarter ending March 31, 2023 was 132M shares, a 31.1% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 132M +31.3M +31.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 131M +31M +31.1% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 127M +30.2M +31.2% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 114M +20.8M +22.3% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 101M +23.9M +31.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 99.8M +23.9M +31.4% Dec 31, 2021 10-K 2023-03-06
Q3 2021 96.7M +23M +31.2% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 93.3M +19.6M +26.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 76.8M +3.07M +4.17% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 75.9M +17.9M +30.9% Dec 31, 2020 10-K 2022-03-31
Q3 2020 73.7M +15.7M +27.1% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 73.7M +15.7M +27.1% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 73.7M +15.7M +27.1% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 58M -6.35K -0.01% Dec 31, 2019 10-K 2021-03-17
Q3 2019 58M -9.98K -0.02% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 58M -6.2K -0.01% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 58M -1.58K 0% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 58M +15M +34.9% Dec 31, 2018 10-K 2020-03-13
Q3 2018 58M +15M +34.9% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 58M +15M +34.9% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 58M +29.8M +105% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 43M +14.7M +52.2% Dec 31, 2017 10-K 2019-03-13
Q3 2017 43M -240M -84.8% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 43M -240M -84.8% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 28.2M -252M -89.9% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 28.2M +182K +0.65% Dec 31, 2016 10-K 2018-03-07
Q3 2016 283M +90.7M +47.3% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 283M +102M +56.8% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 280M +100M +55.5% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 28M -149M -84.1% Dec 31, 2015 10-K 2017-03-02
Q3 2015 192M +41.7M +27.8% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 180M +30.4M +20.3% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 180M +30.4M +20.3% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 177M +31.3M +21.5% Dec 31, 2014 10-K 2016-02-17
Q3 2014 150M +20.3M +15.6% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 150M +35.2M +30.6% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 150M +37.2M +33% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 146M +35.7M +32.5% Dec 31, 2013 10-K 2015-03-12
Q3 2013 130M +67.6M +109% Sep 30, 2013 10-Q 2013-10-30
Q2 2013 115M -146M -56.1% Jun 30, 2013 10-Q 2013-07-31
Q1 2013 113M -114M -50.3% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 110M +69.2M +170% Dec 31, 2012 10-K 2014-03-04
Q3 2012 62.3M -131M -67.7% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 261M Jun 30, 2012 10-Q 2012-08-02
Q1 2012 227M Mar 31, 2012 10-Q 2012-04-20
Q4 2011 40.6M -95M -70.1% Dec 31, 2011 10-K 2013-02-28
Q3 2011 193M Sep 30, 2011 10-Q 2011-10-25
Q4 2010 136M Dec 31, 2010 10-K 2012-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.